Theophyl and Ibandronate sodium drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Theophyl (theophylline) and Ibandronate sodium (ibandronate sodium). Common drug interactions include anaemia among females.
The phase IV clinical study analyzes what interactions people have when they take Theophyl and Ibandronate sodium. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Theophyl?
Theophyl has active ingredients of theophylline. eHealthMe is studying from 19,174 Theophyl users. Check the latest studies of Theophyl.
What is Ibandronate sodium?
Ibandronate sodium has active ingredients of ibandronate sodium. It is often used in osteoporosis post-menopausal. eHealthMe is studying from 3,549 Ibandronate sodium users. Check the latest studies of Ibandronate sodium.
11 people who take Theophyl and Ibandronate sodium together, and have interactions are studied.

What are the common drug interactions of Theophyl and Ibandronate Sodium, by gender? *:
female:
- Anaemia (lack of blood)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Delirium (wild excitement)
- Erysipelas (bacterial skin infection)
- Hypercapnia (too much smoke)
- Lung disorder (lung disease)
- Pain
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Urinary tract infection
male:
n/a
What are the common drug interactions of Theophyl and Ibandronate Sodium, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Sleep disorder
60+:
- Anaemia (lack of blood)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
- Delirium (wild excitement)
- Erysipelas (bacterial skin infection)
- Hypercapnia (too much smoke)
- Lung disorder (lung disease)
- Pain
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Urinary tract infection
What are the existing conditions these people have? *
- Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 18.18%
- Quit Smoking: 2 people, 18.18%
- Osteoporosis (bones weak and more likely to break): 2 people, 18.18%
- High Blood Cholesterol: 2 people, 18.18%
- Dyspnea (difficult or laboured breathing): 2 people, 18.18%
- Rickets (softening of bones): 1 person, 9.09%
- Gastritis (inflammation of stomach): 1 person, 9.09%
- Alkalosis: 1 person, 9.09%
- Asthma: 1 person, 9.09%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Theophyl and Ibandronate sodium?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Theophyl (19,174 reports)
- Ibandronate sodium (3,549 reports)
Browse all drug interactions of Theophyl and Ibandronate sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Theophyl:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ibandronate sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Theophyl and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ibandronate sodium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
- Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
- Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
- Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on theophylline and ibandronate sodium (the active ingredients of Theophyl and Ibandronate sodium, respectively), and Theophyl and Ibandronate sodium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Methocarbamol cause Ankle Fracture? - 5 seconds ago
- Could Adcirca cause Autoimmune Hepatitis? - 13 seconds ago
- Drug interactions of Betamethasone Dipropionate and Lantus - 22 seconds ago
- Could Valacyclovir cause Blood Immunoglobulin A Decreased? - 28 seconds ago
- Multiple Sclerosis Relapse and Hepatocellular Injury - 28 seconds ago
- Drug interactions of Zofran Odt and Xanax - 29 seconds ago
- Drug interactions of Keflex and Adderall - 33 seconds ago
- Nephrogenic Anaemia and Consciousness - Decreased - 33 seconds ago
- Drug interactions of Mometasone Furoate and Tylenol W/ Codeine - 44 seconds ago
- Could Ketorolac Tromethamine cause Fainting? - 50 seconds ago